Endotracheal Tube Market Size, Share & Trends Analysis Report By Product Type (Regular Endotracheal Tube, Reinforced Endotracheal Tube), By Route Type, By Application, By End-use, By Region, And Segment Forecasts, 2021 - 2028

Report Overview

The global endotracheal tube market size was valued at USD 1.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028. There is an increasing demand for endotracheal tubes owing to the rising number of surgical procedures due to increasing incidences of chronic diseases such as cardiovascular disease, cancer, and other respiratory diseases. As per World Health Organization Report 2019, respiratory diseases are the leading cause of death globally which accounts for around 4.0 million deaths every year. Hence, the market is expected to show lucrative growth over the forecast period.

A significant increase in surgeries has fueled the demand for endotracheal tubes. According to the Global Surgery and Anaesthesia Statistics report, around 313.0 million procedures are performed each year. Technological advancements in endotracheal intubation have lowered the risk of infection associated with tubes and have also increased product safety. Recently increasing occurrence of Ventilator-associated Pneumonia (VAP) is most widely seen in patients who are on the endotracheal tube or mechanical ventilator for more than 48 hours. Thus, many players in the market are developing products with antimicrobial coating and anti-coagulant coating properties which can reduce VAP. For example, Medtronic Shiley Evac endotracheal tubes have been stated to reduce the VAP by 50.0%.

Hence with the rising incidence of VAP, the demand for coated endotracheal tubes is increasing which will further fuel the market growth. Therefore, technological advancement in endotracheal tubes and a growing aging population that is highly prone to various chronic diseases will further elevate the growth opportunities for the market during the forecast period.

The advent of COVID-19 has greatly surged the demand for endotracheal tubes as breathing difficulty is one clear indication of infection which, in turn, boosted market growth. American Association for Bronchology and Interventional Pulmonology has suggested performing Open Surgical Tracheostomy (OST) or percutaneous dilatational tracheostomy in case of respiratory failure in COVID patients. This pandemic paved way for emergency product approvals. For instance, a U.S.-based biotech firm, N8, secured emergency use authorization from Health Canada For its CeraSheild Endotracheal Tubes in mechanically ventilated COVID-19 patients.

The company patented product has an anti-fouling coating that is conceived to avert deadly bacterial infections. Endotracheal intubation and ventilation support a COVID-19 patient's breathing so the patient’s body can survive as the immune system fights the virus. This means a better chance of fighting off the virus. Such scenarios are expected to boost market growth

Product Type Insights

The regular endotracheal tube segment dominated the market and held the largest revenue share of 32.0% in 2020 due to the increasing number of surgical procedures owing to the increasing prevalence of respiratory diseases. Also, due to increasing cases of VAP, the demand for regular endotracheal tube is seen increasing in the future. Hence, due to this reason the segment is expected to show lucrative growth over the forecast period. Based on product type, the market has been segmented into regular endotracheal tube, reinforced endotracheal tube, preformed endotracheal tube, and double lumen endotracheal tube.

However, the reinforced endotracheal tube segment is anticipated to witness higher growth over the forecast period owing to its rising use during the surgery, and also due to recent technological development made in endotracheal tube. Additionally, the rising incidence of road accidents and trauma injuries will further boost the segment growth during the forecast period.

Route Type Insights

The orotracheal segment dominated the market and held the largest revenue share of 64.9% in 2020. Based on route type, the market has been categorized into orotracheal, and nasotracheal. Orotracheal has the highest market share owing to its high applicability, increased usage, and comfortability. Orotracheal intubation is used to control the airway in a patient undergoing any surgery. It is also used for critically ill patients with a serious injury or multisystem diseases.

In case of emergencies such as respiratory or cardiac arrest, inadequate oxygenation or ventilation, failure to protect the airway from aspiration, and existing or anticipated airway obstruction the orotracheal incubation is most widely used. Due to this reason, the demand for orotracheal tubes is seen increasing in recent years and hence the segment is expected to show lucrative growth over the forecast period. Also, aforementioned factors will increase the demand for orotracheal intubation during the forecast period. The nasotracheal segment is anticipated to witness the fastest CAGR of 5.6% over the forecast period owing to the increase in the prevalence of the respiratory disease.

Application Insights

The emergency treatment segment dominated the market and held the largest revenue share of 55.5% in 2020. Based on application, the market is further categorized into emergency treatment, therapy, and others. The largest share of this segment can be attributed to the growing incidence of emergency conditions such as cardiac arrest and respiratory, airway obstruction as well as inadequate ventilation, rising cases of road accident, and increasing disposable income in developing countries.

However, the therapy segment is expected to show higher growth during forecast period. Growing volume of surgeries, increasing prevalence of chronic respiratory diseases, and rising aging population are major factors responsible for the segment growth during the forecast period.

End-use Insights

The hospitals segment held the largest revenue share of over 34.3% in 2020 owing to the increasing trend of hospitalization worldwide. On basis of end-use, the market has been categorized into hospitals, ambulatory surgical centers, clinics, and others. In addition, high awareness among the physicians and nursing staff at hospital settings is contributing to the larger market share of the segment.

The clinics segment is expected to observe the highest growth over the forecast period. Increasing prevalence of respiratory chronic diseases, rising awareness pertaining to benefits of clinics as well as fair reimbursement policies will escalate the growth of this segment. However, ambulatory surgical centers are also expected to show significant growth during the forecast period due to its increasing centers in North America and Asia Pacific.

Regional Insights

North America dominated the endotracheal tubes market and accounted for the largest revenue share of over 37.9% in 2020 owing to the advanced healthcare system and the growing prevalence of chronic diseases in the country. In addition, the presence of major players in the region contributed to market growth. Prominent players operating in the region include Teleflex Incorporated, Medline Industries, and Medtronic.

In Asia Pacific, the market is anticipated to witness the fastest growth over the forecast period. Increasing geriatric population with respiratory disease, growing prevalence of ventilator-associated pneumonia and increasing number of surgeries due to chronic cardiovascular is anticipated to increase the demand for endotracheal tube in the region.

Key Companies & Market Share Insights

Key parameter affecting the competitive nature of the market is the rapid adoption of advanced healthcare technology for improved healthcare. Also, to retain market share and diversify the product portfolio, major players are often undertaking mergers and acquisitions along with new product launches. Some of the prominent players in the endotracheal tube market include:

• Teleflex Corporation

• Medtronic

• Medline Industries

• Venner Medical

• Sonoma Pharmaceutical

• Hospiteknik Healthcare

• Armstrong Medical

• Airway Innovations

• Smiths Group

• ConvaTec, Inc.

Endotracheal Tube Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2028. For the purpose of this study, Grand View Research has segmented the global endotracheal tube market report on the basis of product type, route type, application, end-use, and region:

• Product Type Outlook (Revenue, USD Million, 2018 - 2028)

  • Regular Endotracheal Tube

  • Reinforced Endotracheal Tube

  • Preformed Endotracheal Tube

  • Double lumen Endotracheal Tube

• Route Type Outlook (Revenue, USD Million, 2018 - 2028)

  • Orotracheal

  • Nasotracheal

• Application Outlook (Revenue, USD Million, 2018 - 2028)

  • Emergency Treatment

  • Therapy

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2028)

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Spain

    • Italy

    • Netherlands

    • Belgium

    • Switzerland

    • Russia

    • Sweden

  • Asia Pacific

    • India

    • Japan

    • China

    • Australia

    • South Korea

    • Malaysia

    • New Zealand

    • Singapore

    • Philippines

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE